Literature DB >> 29166148

In Vivo Differentiation of Uric Acid Versus Non-Uric Acid Urinary Calculi With Third-Generation Dual-Source Dual-Energy CT at Reduced Radiation Dose.

Axelle Franken1, Pierre Alain Gevenois1, Alain Van Muylem2, Nigel Howarth3, Caroline Keyzer1.   

Abstract

OBJECTIVE: The objective of our study was to evaluate in vivo urinary calculus characterization with third-generation dual-source dual-energy CT (DECT) at reduced versus standard radiation dose. SUBJECTS AND METHODS: One hundred fifty-three patients requiring unenhanced CT for suspected or known urolithiasis were prospectively included in our study. They underwent two acquisitions at reduced-dose CT (90 kV and 50 mAsref; Sn150 kV and 31 mAsref, where Sn denotes the interposition of a tin filter in the high-energy beam) and standard-dose CT (90 kV and 50 mAsref; Sn150 kV and 94 mAsref). One radiologist interpreted the reduced-dose examinations before the standard-dose examinations during the same session. Among 103 patients (23 women, 80 men; mean age ± SD, 50 ± 15 years; age range, 18-82 years) with urolithiasis, dedicated DECT software measured the maximal diameter and CT numbers, calculated the DECT number ratio, and labeled with a color code each calculus visualized by the radiologist as uric acid (UA) or non-UA. Volume CT dose index (CTDIvol) and dose-length product (DLP) were recorded.
RESULTS: The radiologist visualized 279 calculi on standard-dose CT and 262 on reduced-dose CT; 17 calculi were missed on reduced-dose CT, all of which were ≤ 3 mm. Among the 262 calculi visualized at both doses, the CT number ratio was obtained with the software for 227 calculi and was not different between the doses (p = 0.093). Among these 262 calculi, 197 were labeled at both doses; 194 of the 197 labeled calculi were labeled with the same color code. Among the 65 remaining calculi, 48 and 61 (all ≤ 5 mm) were not labeled at standard-dose and reduced-dose CT (p = 0.005), respectively. At reduced-dose CT, the mean CTDIvol was 2.67 mGy and the mean DLP was 102.2 mGy × cm.
CONCLUSION: With third-generation dual-source DECT, a larger proportion of calculi ≤ 5 mm are not characterized as UA or non-UA at a reduced dose.

Entities:  

Keywords:  CT number ratio; dual-energy CT; radiation dose; uric acid; urinary calculi

Mesh:

Substances:

Year:  2017        PMID: 29166148     DOI: 10.2214/AJR.17.18091

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  5 in total

1.  Low-dose dual-energy CT for stone characterization: a systematic comparison of two generations of split-filter single-source and dual-source dual-energy CT.

Authors:  Dominik Nakhostin; Thomas Sartoretti; Matthias Eberhard; Bernhard Krauss; Daniel Müller; Hatem Alkadhi; André Euler
Journal:  Abdom Radiol (NY)       Date:  2020-11-07

2.  Influence of Radiation Dose, Photon Energy, and Reconstruction Kernel on rho/z Analysis in Spectral Computer Tomography: A Phantom Study.

Authors:  Vasiliki Chatzaraki; Alessandra Bolsi; Rahel A Kubik-Huch; Bernhard Schmidt; Antony John Lomax; Damien C Weber; Michael Thali; Tilo Niemann
Journal:  In Vivo       Date:  2022 Mar-Apr       Impact factor: 2.155

3.  Diagnostic accuracy of third-generation dual-source dual-energy CT: a prospective trial and protocol for clinical implementation.

Authors:  Tim Nestler; Kai Nestler; Andreas Neisius; Hendrik Isbarn; Christopher Netsch; Stephan Waldeck; Hans U Schmelz; Christian Ruf
Journal:  World J Urol       Date:  2018-08-03       Impact factor: 4.226

Review 4.  [Update of the 2Sk guidelines on the diagnostics, treatment and metaphylaxis of urolithiasis (AWMF register number 043-025) : What is new?]

Authors:  C Seitz; T Bach; M Bader; W Berg; T Knoll; A Neisius; C Netsch; M Nothacker; S Schmidt; M Schönthaler; R Siener; R Stein; M Straub; W Strohmaier; C Türk; B Volkmer
Journal:  Urologe A       Date:  2019-11       Impact factor: 0.639

5.  Spectral Properties of Abdominal Tissues on Dual-energy Computed Tomography and the Effects of Contrast Agent.

Authors:  Diana A Kreul; Rahel A Kubik-Huch; John Froehlich; Michael J Thali; Tilo Niemann
Journal:  In Vivo       Date:  2021 Nov-Dec       Impact factor: 2.155

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.